Palliative Management of Inoperable Malignant Bowel Obstruction: Prospective, Open Label, Phase 2 Study at an NCI Comprehensive Cancer Center

Michelle Walter1, Eric Hansen1, Showkat Hamid2, Desi Carozza1, Gary Mann3, Charles Roche4, Anthony George5, Kristopher Attwood5, Amy Case1
1Department of Palliative and Supportive Care (M.W., E.H., D.C., A.C.), Rowell Park Comprehensive Cancer Center, Buffalo, NY, USA
2Department of Medicine (S.H.), Rowell Park Comprehensive Cancer Center, Buffalo, NY, USA
3Department of Surgical Oncology (G.M.), Rowell Park Comprehensive Cancer Center, Buffalo, NY, USA
4Department of Diagnostic Radiology (C.R.), Rowell Park Comprehensive Cancer Center, Buffalo, NY, USA
5Department of Biostatistics and Bioinformatics (A.G., K.A.), Rowell Park Comprehensive Cancer Center, Buffalo, NY, USA

Tài liệu tham khảo

Tuca, 2012, Malignant bowel obstruction in advanced cancepatients: epidemiology, management, and factors influencing spontaneous resolution, Cancer Manag Res, 4, 159, 10.2147/CMAR.S29297 Lilley, 2018, Survival, healthcare utilization, and end-of-life care among older adults with malignancy-associated bowel obstruction: comparative study of surgery, venting gastrostomy, or medical management, Ann Surg, 267, 692, 10.1097/SLA.0000000000002164 Ripamonti, 2015, Bowel obstruction, 9119 Pujara, 2017, Selective approach for patients with advanced malignancy and gastrointestinal obstruction, J Am Coll Surg, 225, 53, 10.1016/j.jamcollsurg.2017.04.033 Henry, 2012, A scoring system for the prognosis and treatment of malignant bowel obstruction, Surgery, 152, 747, 10.1016/j.surg.2012.07.009 Tang, 2019, Colonic stenting for malignant large bowel obstruction is safe and effective: a single-surgeon experience, Singapore Med J, 60, 347, 10.11622/smedj.2019010 Lee, 2012, Preliminary study of enteroscopy-guided, self-expandable metal stent placement for malignant small bowel obstruction, J Gastroenterol Hepatol, 27, 1181, 10.1111/j.1440-1746.2012.07113.x Davis, 2021, Medical management of malignant bowel obstruction in patients with advanced cancer: 2021 MASCC guideline update, Support Care Cancer, 29, 8089, 10.1007/s00520-021-06438-9 Kucukmetin, 2010, Palliative surgery versus medical management for bowel obstruction in ovarian cancer, Cochrane Database Syst Rev, 2010 Bleicher, 2021, A palliative approach to management of peritoneal carcinomatosis and malignant ascites, Surg Oncol Clin N Am, 30, 475, 10.1016/j.soc.2021.02.004 Mercadante, 2004, Aggressive pharmacological treatment for reversing malignant bowel obstruction, J Pain Symptom Manage, 28, 412, 10.1016/j.jpainsymman.2004.01.007 Prommer, 2008, Established and potential therapeutic applications of octreotide in palliative care, Support Care Cancer, 16, 1117, 10.1007/s00520-007-0399-4 Tradounsky, 2012, Palliation of gastrointestinal obstruction, Can Fam Physician, 58 Dans M, Walling A et al. National Comprehensive Cancer Network. Palliative Medicine (version 2.2023). Available at: https://www.nccn.org/professionals/physician_gls/pdf/palliative.pdf. Accessed August 14, 2023. Berger, 2016, Medical therapy of malignant bowel obstruction with octreotide, dexamethasone, and metoclopramide, Am J Hosp Palliat Care, 33, 407, 10.1177/1049909115569047 Wey, 2021, Palliative medical management of inoperable malignant bowel obstruction with “triple therapy”: dexamethasone, octreotide, and metoclopramide, Am J Hosp Palliat Care, 38, 340, 10.1177/1049909120968249 Chang, 2004, Shorter symptom assessment instruments: the Condensed Memorial Symptom Assessment Scale (CMSAS), Cancer Invest, 22, 526, 10.1081/CNV-200026487